MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

21st International Congress » Cognitive Disorders

Date: Wednesday, June 7, 2017

Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Meeting: 21st International Congress

1:15pm-2:45pm
[11C]PK11195 PET Imaging Reveals Neuroinflammation in Dementia with Lewy Bodies: NIMROD Study

A. Surendranathan, L. Su, L. Passamonti, Y. Hong, W. Bevan-Jones, R. Arnold, P. Vázquez Rodríguez, E. Mak, T. Fryer, F. Aigbirhio, J. Rowe, J. O'Brien (Cambridge, United Kingdom)

1:15pm-2:45pm
Adding cues to a rat gambling task potentiates the increase in premature responding in response to chronic D2/3 agonist ropinirole without mitigating preference for risk

M. Tremblay, M. Barrus, P. Cocker, S. Kaur, C. Winstanley (Vancouver, BC, Canada)

1:15pm-2:45pm
An unusual case of sporadic Creutzfeld Jacob disease presenting as acute neuropathy

R. Hanumanthu, A. Alchaki, A. Nyaboga, H. Ghuman, J. Chen, E. Feinstein (Newark, NJ, USA)

1:15pm-2:45pm
Assessment of cognitive impairment using FP-CIT SPECT

N. Egawa, A. Kokuryu, Y. Inoue, A. Kuzuya, R. Takahashi (Kyoto, Japan)

1:15pm-2:45pm
Cholinergic activity, mobility, and attention in mild cognitive impairment

D. Martini, K. Smulders, A. Hiller, K. Chung, J. Quinn, F. Horak (Portland, OR, USA)

1:15pm-2:45pm
Cognitive and demographic predictors of progression to MCI and dementia in Parkinson’s disease

B. Cholerton, C. Johnson, B. Fish, J. Quinn, K. Chung, A. Peterson-Hiller, L. Rosenthal, T. Dawson, M. Albert, S.-C. Hu, T. Montine, J. Leverenz, C. Zabetian, K. Edwards (Stanford, CA, USA)

1:15pm-2:45pm
Difficulties in executing the MDS recommendations in the brazilian population

E. Carreira, E. CARREIRA, A. PRADO, N. BRAZ, F. TAVARES, N. ROCHA, L. DE SOUZA, F. CARDOSO, A. TEIXEIRA (Belo Horizonte, Brazil)

1:15pm-2:45pm
Effects of zonisamide, an anti-parkinsonian drug, on cognition and BPSD in DLB patients: A post-hoc analysis of DLB Ph2 study

M. Murata, T. Odawara, O. Konishi, M. Nakamura, K. Kosaka (Tokyo, Japan)

1:15pm-2:45pm
Emotion regulation and neuropsychological status in psychogenic subtypes.

B. Scott, A. Strutt, P. Lundberg-Love, A. Schmitt, J. Jankovic, D. Bowers (Gainesville, FL, USA)

1:15pm-2:45pm
Impaired Color Vision in Patients with DLB or Prodromal DLB.

B. Tousi, P. Flanigan, M. Khosravi (Cleveland, OH, USA)

1:15pm-2:45pm
Lack of accurate self-appraisal is equally likely in Mild Cognitive Impairment from Parkinson’s disease and Other Neurodegenerative Disorders

J. Leverenz, A. Bonner-Jackson, D. Floden, H. Fernanadez, J. Pillai (Cleveland, OH, USA)

1:15pm-2:45pm
Late-Onset Wilson’s disease, Dementia, Ekbom syndrome and whitte matter hyperintensities

F. Germiniani, P. Marques, F. Zorzetto, L. de Oliveira, H. Teive (Curitiba, Brazil)

1:15pm-2:45pm
Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

D. Weintraub (Philadelphia, PA, USA)

1:15pm-2:45pm
Neurofilament light chain levels in cerebrospinal fluid do not discriminate between patients with prion disease and mimics

B. Roeben, E. Stransky, K. Brockmann, R. Schüle, W. Maetzler, T. Gasser, G. Machetanz (Tübingen, Germany)

1:15pm-2:45pm
Neuropsychological profile of corticobasal degeneration, progressive supranuclear palsy and frontotemporal dementia patients

M.M. Carmona-Abellan, M. Riverol, M. Recio, B. Echeveste, L. Imaz, R. Luquin (Pamplona, Spain)

1:15pm-2:45pm
Rapidly progressive dementia and parkinsonism caused by a cortical dural AV fistula: a case report

T. Weissfeld, D. Kremens, J. McCall (Philadelphia, PA, USA)

1:15pm-2:45pm
RBD predicts the cognitive impairment in Parkinson’s disease

E. Stefanova, T. Stojkovic, I. Stankovic, V. Kostic (Belgrade, Serbia)

1:15pm-2:45pm
Using eye tracking to identify pupil and saccade biomarkers of neurodegenerative disease

D. Munoz, B. Coe, J. Huang, M. Smorenburg, D. Brien, S. Black, M. Borrie, D. Dowlatshahi, E. Finger, D. Grimes, M. Freedman, A. Lang, C. Marras, M. Masellis, R. Swartz, C. Tartaglia, L. Zinman, t. ONDRI Investigators (Kingston, ON, Canada)

1:15pm-2:45pm
White matter lesions and peripheral vessel reactivity in dementia with Lewy bodies

A. Chimagomedova, E. Vasenina, O. Levin (Moscow, Russian Federation)

« View all sessions from the 21st International Congress.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley